ERBB2 and neoplasm: No significant difference in SEMA3A expression was observed in the tumor cells between subtypes (p = 0.1419) (Table 1) and in tumor vessels among different breast cancer subtypes (luminal A/B, HER2 and TNBC) (p = 0.2263) (Table 2).